Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)
- Supplementary File 1:
ZIP-Document (ZIP, 39 KiB)
Azzari, C.; Moriondo, M.; Nieddu, F.; Guarnieri, V.; Lodi, L.; Canessa, C.; Indolfi, G.; Giovannini, M.; Napoletano, G.; Russo, F.; Baldovin, T.; Cocchio, S.; Ricci, S.; Baldo, V. Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018). Vaccines 2020, 8, 469. https://doi.org/10.3390/vaccines8030469
Azzari C, Moriondo M, Nieddu F, Guarnieri V, Lodi L, Canessa C, Indolfi G, Giovannini M, Napoletano G, Russo F, Baldovin T, Cocchio S, Ricci S, Baldo V. Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018). Vaccines. 2020; 8(3):469. https://doi.org/10.3390/vaccines8030469
Chicago/Turabian StyleAzzari, Chiara, Maria Moriondo, Francesco Nieddu, Valentina Guarnieri, Lorenzo Lodi, Clementina Canessa, Giuseppe Indolfi, Mattia Giovannini, Giuseppina Napoletano, Francesca Russo, Tatjana Baldovin, Silvia Cocchio, Silvia Ricci, and Vincenzo Baldo. 2020. "Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)" Vaccines 8, no. 3: 469. https://doi.org/10.3390/vaccines8030469